Tech Company Financing Transactions
Scribe Therapeutics Funding Round
Scribe Therapeutics, operating out of Alameda, secured $100 million from Avoro Capital Advisors, Andreessen Horowitz and OrbiMed.
Transaction Overview
Company Name
Announced On
3/25/2021
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1150 Marina Village Pkwy.
Alameda, CA 94501
USA
Alameda, CA 94501
USA
Phone
Undisclosed
Website
Email Address
Overview
Scribe was founded by CRISPR leaders from UC Berkeley with an unmatched expertise and track record in CRISPR and protein engineering. Our unique ability to engineer biology will fundamentally transform how we diagnose, treat, and manage disease at scale.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Oakes
Co-Founder
Jennifer Doudna
Co-Founder
David Savage
Vice President
Brett Staahl
VP - Bus. Development
Svetlana Lucas
Browse more venture capital transactions:
Prev: 3/25/2021: WeConvene venture capital transaction
Next: 3/25/2021: 1910 Genetics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs